• 1
    Lakatos PL. Recent trends in the epidemiology of inflammatory bowel diseases: up or down? World J Gastroenterol. 2006; 12: 61026108.
  • 2
    Loftus EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004; 126: 15041517.
  • 3
    Loftus CG, Loftus EV Jr, Harmsen WS, et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000. Inflamm Bowel Dis. 2007; 13: 254261.
  • 4
    Shivananda S, Lennard-Jones J, Logan R, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European collaborative study on inflammatory bowel disease (EC-IBD). Gut. 1996; 39: 690697.
  • 5
    Lakatos L, Lakatos PL. Is the incidence and prevalence of inflammatory bowel diseases increasing in Eastern Europe? Postgrad Med J. 2006; 82: 332337.
  • 6
    Ouyang Q, Tandon R, Goh KL, et al. The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol. 2005; 21: 408413.
  • 7
    Munkholm P, Langholz E, Nielsen OH, et al. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962–87: a sixfold increase in incidence. Scand J Gastroenterol. 1992; 27: 609614.
  • 8
    Vind I, Riis L, Jess T, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003–2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol. 2006; 101: 12741282.
    Direct Link:
  • 9
    Lakatos L, Mester G, Erdelyi Z, et al. Striking elevation in the incidence and prevalence of inflammatory bowel disease in a province of Western Hungary between 1977–2001. World J Gastroenterol. 2004; 10: 404409.
  • 10
    Mijandrusic-Sincic B, Vucelic B, Persic M, et al. Incidence of inflammatory bowel disease in Primorsko-Goranska county, Croatia, 2000–2004. Scand J Gastroenterol. 2006; 41: 437444.
  • 11
    Pavlovic-Calic N, Salkic NN, Gegic A, et al. Crohn's disease in Tuzla region of Bosnia and Herzegovina: a 12-year study (1995–2006). Int J Colorectal Dis. 2008; 23: 957964.
  • 12
    Salkic NN, Pavlovic-Calic N, Gegic A, et al. Ulcerative colitis in the Tuzla region of Bosnia and Herzegovina between 1995 and 2006: epidemiological and clinical characteristics. Eur J Gastroenterol Hepatol. 2010; 22: 346353.
  • 13
    Beaugerie L, Seksik P, Nion-Larmurier I, et al. Predictors of Crohn disease. Gastroenterology. 2006; 130: 650656.
  • 14
    Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol. 1989; 24( suppl 170): 26.
  • 15
    Lakatos L, Pandur T, David G, et al. Association of extraintestinal manifestations of inflammatory bowel disease (IBD) in a province of Western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol. 2003; 9: 23002307.
  • 16
    Stange EF, Travis SPL, Vermeire S, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut. 2006; 55( suppl i): i1i15.
  • 17
    Stange EF, Travis SP, Vermeire S, et al. European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohn Colitis. 2008; 2: 123.
  • 18
    Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005; 19( suppl A): 536.
  • 19
    Stowe SP, Redmond SR, Stormont JM, et al. An epidemiological study of inflammatory bowel disease in Rochester, New York. Hospital incidence. Gastroenterology. 1990; 98; 104110
  • 20
    Solberg IC, Vatn MH, He O, et al. Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol. 2007; 5: 14301438.
  • 21
    Wolters FL, Russel MG, Sijbrandij J, et al. Phenotype at diagnosis predicts recurrence rates in Crohn's disease. Gut. 2006; 55: 11241130
  • 22
    Thia KT, Sandborn WJ, Harmsen WS, et al. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. Gastroenterology. 2010; 139: 11471155.
  • 23
    Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, et al. Early Crohn disease: a proposed definition for use in disease-modification trials. Gut. 2010; 59: 141147.
  • 24
    Lakatos PL, Czegledi Z, Szamosi T, et al. Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn's disease. World J Gastroenterol. 2009; 15: 35043510.
  • 25
    Szamosi T, Banai J, Lakatos L, et al. Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohn's disease, while smoking decreases the risk of colectomy in ulcerative colitis. Eur J Gastroenterol Hepatol. 2010; 22: 872879.
  • 26
    Wolters FL, Joling C, Russel MG, et al. Treatment inferred disease severity in Crohn's disease: evidence for a European gradient of disease course. Scand J Gastroenterol. 2007; 42: 333344.
  • 27
    Jess T, Riis L, Vind I, et al. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis. 2007; 13: 481489
  • 28
    Solberg IC, Lygren I, Jahnsen J, et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol. 2009; 44: 431440.
  • 29
    Hoie O, Wolters FL, Riis L, et al. Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology. 2007; 132: 507515.